John J. Miller

2 weeks ago | psychiatrictimes.com | John J. Miller |Jonathan Meyer

TALKING WITH TITANS OF PSYCHOPHARMACOLOGYAt the 2025 American Psychiatric Association (APA) Annual Meeting, Psychiatric Times' Editor in Chief, John J. Miller, MD, sat down with leaders in psychopharmacology to discuss the topics they find most important. Jonathan M. Meyer, MD, DFAPA, presented on lithium, one of the strongest tools in psychiatry, expanding on our understanding of its mechanisms. How can we develop antidepressant drugs to enhance benefits and minimize adverse events?

2 weeks ago | psychiatrictimes.com | John J. Miller |Roger S. McIntyre

TALKING WITH TITANS OF PSYCHOPHARMACOLOGYAt the 2025 American Psychiatric Association (APA) Annual Meeting, Psychiatric Times' Editor in Chief, John J. Miller, MD, sat down with leaders in psychopharmacology to discuss the topics they find most important. Roger S. McIntyre, MD, FRCPC, has spent several decades dedicated to understanding the impact of insulin and metabolism on the brain.1 "A lightbulb moment for me happened while seeing patients.

2 weeks ago | psychiatrictimes.com | John J. Miller |John H Krystal

TALKING WITH TITANS OF PSYCHOPHARMACOLOGYAt the 2025 American Psychiatric Association (APA) Annual Meeting, Psychiatric Times' Editor in Chief, John J. Miller, MD, sat down with leaders in psychopharmacology to discuss the topics they find most important. John H. Krystal, MD, is best known for leading the discovery of ketamine's rapid antidepressant effects.1,2 He shared his latest insights on NMDA glutamate receptors and ketamine with Miller.

2 weeks ago | psychiatrictimes.com | John J. Miller |Jeffrey Newcorn

TALKING WITH TITANS OF PSYCHOPHARMACOLOGYAt the 2025 American Psychiatric Association (APA) Annual Meeting, Psychiatric Times' Editor in Chief, John J. Miller, MD, sat down with leaders in psychopharmacology to discuss the topics they find most important. Jeffrey Newcorn, MD, has special expertise in the areas of attention-deficit/hyperactivity disorder (ADHD), aggression, descriptive psychopathology of child and adolescent disorders, and child and adolescent psychopharmacology.

2 weeks ago | psychiatrictimes.com | John J. Miller |Jonathan Meyer

TALKING WITH TITANS OF PSYCHOPHARMACOLOGYAt the 2025 American Psychiatric Association (APA) Annual Meeting, Psychiatric Times' Editor in Chief, John J. Miller, MD, sat down with leaders in psychopharmacology to discuss the topics they find most important. Jonathan M. Meyer, MD, DFAPA, is a prolific writer and the author of several books.